Hemianopsy revealing cerebral thrombosis: Role of protein S deficiency induced by L-asparginase;Hémianopsie latérale homonyme révélant une thrombophlébite cérébrale: Rôle d'un déficit en protéine S induit par la L-asparaginase

Presse Medicale

Volumn 30, Issue 17, 2001, Pages 855-857

  Millot, F ^a   Traore, P ^a   Boinot, C ^a   Vandermarcq, P ^a   Sadoun, A ^a   Brizard, A ^a   Guilhot, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; PROTEIN S;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FEMALE; HEMIANOPIA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PROTEIN BLOOD LEVEL; PROTEIN S DEFICIENCY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; BLOOD COAGULATION TESTS; CEREBRAL CORTEX; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMIANOPSIA; HUMANS; INTRACRANIAL EMBOLISM; LEUKEMIA, LYMPHOCYTIC, ACUTE; MAGNETIC RESONANCE IMAGING; PROTEIN S DEFICIENCY; THROMBOPHLEBITIS;

EID: 0035810630     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bosson JL, Francois P, Pemod G, Carpentier P. Venous thrombolic disease in children related to transient protein S deficiency following varicella. Presse Med 1995; 24:415.
2. Engesser L, Broekmans AW, Briet E, Brommer EJ, Bertina RM. Hereditary protein S deficiency : clinical manifestations. Ann Inter Med 1987; 106:677-82.
3. Kaplan RS, Wiemick PH. Neurotoxidty of antineoplastic drugs. Semin Oncol 1985 ; 9:103-15.
4. SW Cosgriff. Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 1951; 147:924-8.
5. Meininger V, James JM, Rio B, Zittoun R. Occlusions des sinus veineux de la dure-mère au cours des hémopathies. Rev Neurol 1985; 141:228-33.
6. Nowak-gottl U, Dubber A, Kececioglu D et al. Factor V Leiden, protein C and lipoprotein a in catheter related thrombosis in childhood : a prospective study. J Pediatr 1997 ; 131:608-612.
7. Kucuk O, Hau C, Kwaan HC, Gunnar W, RM Vasquez. Thromboembolic complications associated with L-asparaginase therapy. Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma. Cancer 1985; 55:702-6.
8. Mitchell L, Hoogendoorm H, Giles AR, Vegh P, Andrew M. Increased endogenous thrombin generation in children with acute lymphoblastic leukemia : risk of thrombotic complications in L-Asparaginase-induced antithrombin III deficiency. Blood 1994 ; 85:386-91.
9. Bezaud A, Drouet L, Leverger G, Griffin JH, MC Guillin Effect of L-asparaginase therapy for acute lymphoblastic leukemia on plasma vitamin K-dependent coagulation factors and inhibitors. J Pediatr 1986 ; 108:698-701.
10. Mitchell LG, Halton JM, Vegh PA. Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia. Am J Pediatr Hematol Oncol 1994 ; 16:120-6.
11. Nowak-gotti U, C Wermes, R Junker et al. Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G202 10A variant and further prothrombotic risk factors. Blood 1999; 93:1595-9.
12. Mauz-korholz C, Junker R, Goebel U, Nowattt-gottl U. Prothrombic risk factors in children with acute lymphoblastic leukemia treated with delayed E.coli asparaginase (COALL-92 and 97 protocol). Thromb Haemost 2000 ; 83:840-3.
13. Ott N, Ramsay NK, Priest JR et al. Sequelae of thrombotic or hemorragic complications following L-asparaginase therapy for childhood lymphoblastic leukemia. Am J Ped Hematol Oncol 1988; 10:191-5.